INGN News and Press, Inogen Inc From 02/27/24

Fourth quarter 2023 revenue of $75.9 million; full-year 2023 revenue of $315.7 million Inogen, Inc . (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the fourth quarter a...

First Solar Inc. (FSLR) is expected to report $3.19 for Q4 2023 VIZIO Holding Corp. Class A (VZIO) is expected to report $0.02 for Q4 2023 Henry Schein Inc. (HSIC) is expected to report $0.71 for Q4 2023 Republic Services Inc. (RSG) is expected to report $1.28 for Q4 2023 Forge Gl...

2024-02-15 15:30:02 ET William Blair analyst issues OUTPERFORM recommendation for INGN on February 15, 2024 02:30PM ET. INGN was trading at $10.37 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current analyst recommendations are : 1 - Buy, ...

2024-02-15 13:41:14 ET More on Inogen Inogen: Time To Be Greedy When Others Are Fearful Seeking Alpha’s Quant Rating on Inogen Historical earnings data for Inogen Financial information for Inogen Read the full article on Seeking Alpha F...

2024-02-15 10:00:00 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming Communication Services, Info ...

2024-02-12 08:34:12 ET DIH Holdings US ( DHAI ) +115% . Millennium Group International  ( MGIH ) +111% . Beamr Imaging  ( BMR ) +72% NVIDIA team up to accelerate adoption of the newest video standard - AV1. ContextLogic  ( WISH ) +38%...

Inogen, Inc. (Nasdaq: INGN ), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that it will report fourth quarter and full year 2023 financial results after the market closes on Tuesday, February 27, 2024. On the same day...

2024-01-24 16:04:06 ET More on Inogen Inogen: Time To Be Greedy When Others Are Fearful Inogen, Inc. (INGN) Q3 2023 Earnings Call Transcript Read the full article on Seeking Alpha For further details see: Inogen names Michael Bourque as CFO

Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the appointment of Michael Bourque as Chief Financial Officer, effective March 4, 2024. Mr. Bourque has served as Treasurer and Chief Financial Offic...

2024-01-07 17:18:52 ET More on Akoya Biosciences, Exact Sciences, etc. Guardant Health: Vast Market Opportunity, Challenging Valuation Illumina: The Divestiture Of Grail Could Unlock Significant Shareholder Value Illumina: Conditions Are Met For A Rebound Nan...